337 related articles for article (PubMed ID: 12952927)
41. Hydroxylases involved in vitamin D metabolism are differentially expressed in murine embryonic kidney: application of whole mount in situ hybridization.
Yamagata M; Kimoto A; Michigami T; Nakayama M; Ozono K
Endocrinology; 2001 Jul; 142(7):3223-30. PubMed ID: 11416045
[TBL] [Abstract][Full Text] [Related]
42. Regulation of messenger ribonucleic acid expression of 1 alpha,25-dihydroxyvitamin D3-24-hydroxylase in rat osteoblasts.
Nishimura A; Shinki T; Jin CH; Ohyama Y; Noshiro M; Okuda K; Suda T
Endocrinology; 1994 Apr; 134(4):1794-9. PubMed ID: 8137744
[TBL] [Abstract][Full Text] [Related]
43. Synthesis of 25-hydroxyvitamin D3-26,23-lactone but not 24,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3 in opossum kidney cells treated with 1 alpha, 25-dihydroxyvitamin D3.
Horiuchi N; Saikatsu S; Akeno N; Abe M; Kimura S; Yamada S
Horm Metab Res; 1995 Feb; 27(2):83-9. PubMed ID: 7759063
[TBL] [Abstract][Full Text] [Related]
44. What have we learnt about the regulation of phosphate metabolism?
Blumsohn A
Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):397-401. PubMed ID: 15199289
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
Drezner MK; Lyles KW; Haussler MR; Harrelson JM
J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
[TBL] [Abstract][Full Text] [Related]
46. Postprandial adjustments in renal phosphate excretion do not involve a gut-derived phosphaturic factor.
Lee GJ; Mossa-Al Hashimi L; Debnam ES; Unwin RJ; Marks J
Exp Physiol; 2017 Apr; 102(4):462-474. PubMed ID: 28130860
[TBL] [Abstract][Full Text] [Related]
47. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
48. 1alpha-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene.
Tenenhouse HS; Gauthier C; Chau H; St-Arnaud R
Am J Physiol Renal Physiol; 2004 Apr; 286(4):F675-81. PubMed ID: 14656762
[TBL] [Abstract][Full Text] [Related]
49. Gene profiling the effects of calcium deficiency versus 1,25-dihydroxyvitamin D induced hypercalcemia in rat kidney cortex.
Bajwa A; Horst RL; Beckman MJ
Arch Biochem Biophys; 2005 Jun; 438(2):182-94. PubMed ID: 15913539
[TBL] [Abstract][Full Text] [Related]
50. Variable in vivo regulation of rat vitamin D-dependent genes (osteopontin, Ca,Mg-adenosine triphosphatase, and 25-hydroxyvitamin D3 24-hydroxylase): implications for differing mechanisms of regulation and involvement of multiple factors.
Matkovits T; Christakos S
Endocrinology; 1995 Sep; 136(9):3971-82. PubMed ID: 7649106
[TBL] [Abstract][Full Text] [Related]
51. Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.
Larsson T; Marsell R; Schipani E; Ohlsson C; Ljunggren O; Tenenhouse HS; Jüppner H; Jonsson KB
Endocrinology; 2004 Jul; 145(7):3087-94. PubMed ID: 14988389
[TBL] [Abstract][Full Text] [Related]
52. [The role of phosphatonin in phosphate metabolism].
Hara S; Iida R; Yoshida H; Ohkido I; Shigematsu T
Clin Calcium; 2005 Jul; 15(7):124-30. PubMed ID: 15995308
[TBL] [Abstract][Full Text] [Related]
53. Regulation of 25-hydroxyvitamin D3 1alpha-hydroxylase, 1,25-dihydroxyvitamin D3 24-hydroxylase and vitamin D receptor gene expression by 8-bromo cyclic AMP in cultured human syncytiotrophoblast cells.
Avila E; Díaz L; Halhali A; Larrea F
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):115-9. PubMed ID: 15225757
[TBL] [Abstract][Full Text] [Related]
54. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
[TBL] [Abstract][Full Text] [Related]
55. Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23.
Perwad F; Portale AA
Mol Cell Endocrinol; 2011 Dec; 347(1-2):17-24. PubMed ID: 21914460
[TBL] [Abstract][Full Text] [Related]
56. Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties.
Nelson AE; Hogan JJ; Holm IA; Robinson BG; Mason RS
Bone; 2001 Apr; 28(4):430-9. PubMed ID: 11336925
[TBL] [Abstract][Full Text] [Related]
57. Investigation of the mechanism for abnormal renal 25-hydroxyvitamin D3-1-hydroxylase activity in the X-linked Hyp mouse.
Tenenhouse HS
Endocrinology; 1984 Aug; 115(2):634-9. PubMed ID: 6086274
[TBL] [Abstract][Full Text] [Related]
58. Regulation of renal vitamin D-24-hydroxylase by phosphate: effects of hypophysectomy, growth hormone and insulin-like growth factor I.
Wu S; Grieff M; Brown AJ
Biochem Biophys Res Commun; 1997 Apr; 233(3):813-7. PubMed ID: 9168939
[TBL] [Abstract][Full Text] [Related]
59. Phosphaturic action of fibroblast growth factor 23 in Npt2 null mice.
Tomoe Y; Segawa H; Shiozawa K; Kaneko I; Tominaga R; Hanabusa E; Aranami F; Furutani J; Kuwahara S; Tatsumi S; Matsumoto M; Ito M; Miyamoto K
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1341-50. PubMed ID: 20357029
[TBL] [Abstract][Full Text] [Related]
60. Colon-specific regulation of vitamin D hydroxylases--a possible approach for tumor prevention.
Kállay E; Bises G; Bajna E; Bieglmayer C; Gerdenitsch W; Steffan I; Kato S; Armbrecht HJ; Cross HS
Carcinogenesis; 2005 Sep; 26(9):1581-9. PubMed ID: 15905206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
